Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Common Share (Schedule of Diluted Weighted Average Shares Outstanding) (Details)

v3.22.1
Net Loss per Common Share (Schedule of Diluted Weighted Average Shares Outstanding) (Details) - $ / shares
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Common Stock, par value $ 0.001   $ 0.001
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 24,140,746 22,057,156  
Warrants to Purchase Common Stock [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 4,505,621 4,579,954  
Options to Purchase Common Stock [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 820,990 853,490  
Unvested Restricted Stock [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 18,710,303 16,391,786  
Unvested Restricted Stock Units [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 103,832 231,926